UpHealth

UpHealth, Inc. operates as a digital health company. It integrates care delivery across the globe to support healthier individuals and communities. It operates through the following segments: the Integrated Care Management, the Global Telehealth, the Digital Pharmacy, the Behavioral Health and the Corporate. The Integrated Care Management segment provides customers with an advanced and extensible technology platform, marketed under the umbrella “SyntraNetTM” to manage health, quality of care, and costs, especially for individuals with complex medical, behavioral health, and social needs. The Global Telehealth segment provides customers with primary care, specialty consultations, and translation services, through telemedicine, digital dispensaries, and technology-based hospital centers. The Digital Pharmacy segment provides custom compounded medications for the unique needs of every patient and prescriber. The Behavioral Health segment provides inpatient and outpatient substance abuse and mental health treatment services for individuals with drug and alcohol addiction and other behavioral health issues. It also offers a complete continuum of care from detoxification services, residential care, partial hospitalization programs, and intensive outpatient and outpatient programs. The Corporate segment performs executive, administrative, finance, human resources, legal, and information technology services for the company. The company was founded by Chirinjeev Kathuria and Mariya Pylypiv and is headquartered in Delray Beach, FL.

Earnings data Q1 2023

Earnings data Q2 2023

DELRAY BEACH, Fla., March 13, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it has closed its previously announced private placement with a single, healthcare-focused institutional investor for the purchase and sale of 3,000,000 shares of the Company's common stock (or common stock equivalents in lieu thereof) together with series A warrants to purchase up to 3,000,000 shares of common stock and series B warrants to purchase up to 3,000,000 shares of the Company's common stock at a purchase price per share (and accompanying series A and series B warrants) of $1.50 resulting in total gross proceeds of approximately $4.5 million before deducting placement agent commissions and other estimated offering expenses. The series A and series B warrants have an exercise price of $2.04 per share and are initially exercisable beginning six months following the date of issuance. The series A warrants will expire five years from the initial exercise date, and the series B warrants will expire 2 years from the initial exercise date.

UpHealth, Inc. Announces Closing of $4.5 Million Private Placement

DELRAY BEACH, Fla., March 09, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it has entered into a definitive agreement with a single, healthcare-focused institutional investor for the purchase and sale of 3,000,000 shares of the Company's common stock (or common stock equivalents in lieu thereof) together with series A warrants to purchase up to 3,000,000 shares of common stock and series B warrants to purchase up to 3,000,000 shares of the Company's common stock at a purchase price per share (and accompanying series A and series B warrants) of $1.50, pursuant to a private placement, resulting in total gross proceeds of approximately $4.5 million before deducting placement agent commissions and other estimated offering expenses. The series A and series B warrants will have an exercise price of $2.04 per share and will be initially exercisable beginning six months following the date of issuance. The series A warrants will expire five years from the initial exercise date, and the series B warrants will expire 2 years from the initial exercise date. The closing of the offering is expected to occur on or about March 13, 2023, subject to the satisfaction of customary closing conditions.

UpHealth, Inc. Announces $4.5 Million Private Placement

UpHealth, Inc. (NYSE:UPH ) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Shannon Devine - Managing Director, MZ North America Samuel Meckey - Chief Executive Officer Martin Beck - Chief Financial Officer Conference Call Participants Mike Latimore - Northland Capital Markets Operator Greetings, and welcome to the UpHealth Fourth Quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode.

UpHealth, Inc. (UPH) Q4 2022 Earnings Call Transcript

UpHealth, Inc. (UPH) delivered earnings and revenue surprises of -243.40% and 2.92%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

UpHealth, Inc. (UPH) Reports Q4 Loss, Tops Revenue Estimates

Fourth Quarter Revenues Increased 20 % to $40.5 million ; Adjusting for Deconsolidation of Glocal, Revenue Increased 32%

UpHealth Announces Fourth Quarter 2022 Financial Results

DELRAY BEACH, FL, Feb. 27, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its fourth quarter and full year ended December 31, 2022, before the market opens on Thursday, March 2, 2023.

UpHealth Announces Timing of Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

UpHealth, Inc. (UPH) delivered earnings and revenue surprises of -525% and 18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

UpHealth, Inc. (UPH) Reports Q3 Loss, Lags Revenue Estimates

Third Quarter Revenues of $38.7 million ; Gross Margin of 48% ; Adjusted EBITDA of $(1.2) million Revenues for the Nine-Month Period of $118.3 million , Gross Margin of 48% ; Adjusted EBITDA of $1.4 million Results reflect the deconsolidation of Glocal as of July 2022 due to ongoing control issues and legal proceedings Over 60% of Transformation Initiatives Completed to Date; Company Continues to Add New Leadership Completed Previously Announced $67.5 million Convertible Debt Financing

UpHealth Announces Third Quarter 2022 Financial Results

DELRAY BEACH, Fla., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Healthcare transformation expert Timothy Wilde has joined UpHealth, Inc. (NYSE: UPH) as Chief Technology Officer, effectively immediately. Wilde reports to UpHealth CEO Sam Meckey and will be part of the company's executive leadership team.

Transformation and Technology Expert Timothy Wilde Joins UpHealth as Chief Technology Officer

DELRAY BEACH, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that the previously announced reverse stock split of the Company's issued and outstanding common stock approved by its Board of Directors and the Company's stockholders on December 5, 2022 whereby each ten shares of common stock will be combined and reconstituted into one share of common stock will effect proportionate adjustments to its outstanding warrants.

UpHealth Announces Reverse Stock Split Will Effect Changes to Warrant Terms

Proposed New Independent Board Members Elected

UpHealth Announces Results of First Annual Stockholder Meeting

DELRAY BEACH, Fla., Dec. 05, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that the Company's Board of Directors has approved a 10:1 reverse stock split of the Company's issued and outstanding common stock.

UpHealth to Effect 10:1 Reverse Stock Split

DELRAY BEACH, Fla. , Oct. 27, 2022 /PRNewswire/ -- Melissa Frieswick, a healthcare industry veteran, has joined UpHealth Inc. (NYSE: UPH) as chief growth officer, effective immediately.

Healthcare Veteran Melissa Frieswick joins UpHealth as Chief Growth Officer

DELRAY BEACH, Fla. , Oct. 20, 2022 /PRNewswire/ -- Dr. Mahesh Inder Veer Singh, a noted medical doctor and healthcare management expert, has joined UpHealth Inc. (NYSE: UPH) as executive vice president of UpHealth International, effective immediately.

Dr. Mahesh Inder Veer Singh Joins UpHealth, Inc. as Executive Vice President of UpHealth International

Alameda County Social Health Information Exchange Receives CompTIA Award DELRAY BEACH, Fla. , Oct. 10, 2022 /PRNewswire/ -- SyntraNet by UpHealth, Inc. (NYSE: UPH) and Alameda County Health Care Services Agency's partnership that led to the creation of an integrated, digital care platform to exchange information and coordinate care was recognized for its excellence and innovation among public sector technology solutions.

First-Of-Its-Kind Partnership Between SyntraNet by UpHealth and Alameda County Health Care Services Agency Receives National Recognition for Integrated Care Platform

Destination XL Group

Esports Entertainment Group

Liberty TripAdvisor Hlds

Transocean

Tilray Brands

Regardless of economic cycles, investing in cheap penny stocks is always a good idea. After all,  some of the blue-chip stocks we love today started off as penny stocks, making their early investors tremendous amounts of money.

7 Cheap Penny Stocks to Buy Before They Boom

DELRAY BEACH, Fla. , Aug. 19, 2022 /PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, announced today that it has closed its previously announced sale of $67.5 million in aggregate principal amount of a new series of variable rate convertible senior secured notes due December 15, 2025 (the "2025 Notes") in a private placement transaction.

UPHEALTH ANNOUNCES CLOSING OF $67.5 MILLION CONVERTIBLE DEBT FINANCING

Today, we put UpHealth in the spotlight for the first time. The company is seeing significant revenue growth even if it isn't profitable yet.

UpHealth: The SPAC Disaster 'Du Jour'

UpHealth, Inc. (NYSE:UPH ) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Shannon Devine - Investor Relations Sam Meckey - Chief Executive Officer Martin Beck - Chief Financial Officer Ramesh Balakrishnan - President, Chief Strategy Officer Conference Call Participants Michael Latimore - Northland Capital Markets Frank Takkinen - Lake Street Capital Markets Operator Greetings, and welcome to the UpHealth Second Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode.

UpHealth, Inc. (UPH) CEO Sam Meckey on Q2 2022 Results - Earnings Call Transcript

UpHealth, Inc. (UPH) delivered earnings and revenue surprises of -28.57% and 2.86%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

UpHealth, Inc. (UPH) Reports Q2 Loss, Lags Revenue Estimates

Second Quarter Revenue of $43.7 million, a 21% increase on a Sequential Basis Gross Margin Expanded to 51%, compared to 43% on a Sequential Basis Nearly 50% of Transformation Initiatives Completed To-Date  Subsequent to Quarter End, Company Under New Leadership of CEO Samuel J. Meckey   Announced $67.5M Convertible Debt Financing, Further Extending Company's Maturity Profile  DELRAY BEACH, Fla.

UPHEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS

~ Debt Financing Further Extends Maturity Profile ~ DELRAY BEACH, Fla. , Aug. 15, 2022 /PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the sale of $67.5 million in aggregate principal amount of a new series of variable rate convertible senior secured notes due December 15, 2025 (the "2025 Notes") in a private placement transaction, raising approximately $22.5 million in gross cash proceeds after paying for a repurchase of $45.0 million of its 6.25% convertible senior notes due 2026.

UPHEALTH ANNOUNCES $67.5 MILLION CONVERTIBLE DEBT FINANCING

DELRAY BEACH, Fla. , Aug. 2, 2022 /PRNewswire/ -- UpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company") today announced that the stockholder litigation that resulted in a delay of the Company's 2022 Annual Meeting of Stockholders (the "Annual Meeting") has been withdrawn by the plaintiffs, with the consent of the Company and director defendants (the "Independent Directors").

UpHealth's Independent Directors Welcome the Termination of Litigation that Had Delayed the Annual Stockholder Meeting

Top languages at Parsley Health include Spanish, French, Korean, American Sign Language   DELRAY BEACH, Fla. , July 13, 2022  /PRNewswire/ -- UpHealth, Inc. (NYSE: UPH) and Parsley Health announced a partnership to provide remote language interpretation services to Parsley patients via Martti™ by UpHealth.

UPHEALTH AND PARSLEY HEALTH PARTNER TO BRIDGE DISPARITIES IN HEALTHCARE BY PROVIDING MARTTI™ TELEINTERPRETATION SERVICES ORGANIZATION-WIDE

DELRAY BEACH, Fla. , July 12, 2022 /PRNewswire/ -- UpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company"), a digital-first healthcare solutions company with a suite of advanced tech products and services to improve population health, today announced that it will release financial results for its second quarter ended June 30, 2022, before the market opens on Monday, August 15, 2022.

News for UpHealth Stock (UPH)